SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description

Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

: Conversations in Cardiology: September 8, 2018
Activity/Course #:
: 09.08.18CIC

: Free
Release/Start Date:
: Sep 08 2018
Expiration Date:
: Sep 08 2018
: Cardiovascular
Target Audience:
: Cardiologists and Primary Care Providers
: Live Virtual Conferences
Estimated Time To Complete CME Activity:
: 3.0 hours
: 3.0 AMA PRA Category I Credit(s)
3.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s)
Hardware/Software Requirements:

There is no registration fee for this CME live virtual conference!

September 8, 2018
Broadcast Live from Ft. Lauderdale, FL
Start Time: 10:00 am EDT

Click on the Links Below to View/Print the Slides and Handbook:

Cardiovascular Risk in Diabetes Slides

Amyloidosis Slides

Handbook - Conversations in Cardiology 2018

Program Summary:

Join us for the Association of Black Cardiologists' and the National Association for Continuing Education's Conversations in Cardiology virtual live conference. Utilizing an interactive, moderator led format, this program will help you hone your skills in the diagnosis and management of patients you are likely encountering in your practice. You will be able to interact with the faculty in real-time to get your questions answered.

Topics and Learning Objectives

1. Diabetes and Cardiovascular Disease: Describe the burden of cardiovascular diseases including hypertension, dyslipidemia, coronary artery disease and heart failure in patients with diabetes; Discuss evidence-based recommendations supporting individualization of treatment in patients with type 2 diabetes mellitus; Review the results of cardiovascular outcome trials with new medications for type 2 diabetes; Discuss the role of novel therapies for managing cardiovascular risk in patients with type 2 diabetes.

2. Cardiac Amyloidosis: Describe the different types of cardiac amyloidosis; Recognize the clinical manifestations of hATTR amyloidosis; Implement current strategies for the diagnosis of hATTR amyloidosis; Utilize the most recent clinical evidence to inform decisions about treatment of hATTR amyloidosis.



    10:00-10:10 AM

     Welcome Remarks by Moderator
    Keith Ferdinand, MD, FACC, FAHA, FASH, FNLA
    10:10-11:20 Managing Cardiovascular Risk in Diabetes: New Data and Evolving Strategies
    James R. Gavin, III, MD, PhD
    11:20-12:30 PM Recognizing and Managing hATTR Cardiac Amyloidosis: Bridging Evidence and Clinical Practice
    Icilma V. Fergus, MD, FACC

    Live Panel Q&A

    Closing Remarks
    Keith Ferdinand, MD, FACC, FAHA, FASH, FNLA
* Subject to Change


James R. Gavin III, MD, PhD
Clinical Professor of Medicine
Emory University School of Medicine
Atlanta, GA

Icilma V. Fergus, MD, FACC
Director Cardiovascular Disparities
Associate Professor of Medicine
Mount Sinai School of Medicine
New York, NY


Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASH
Professor of Medicine, Tulane University School of Medicine
Tulane Heart and Vascular Institute
New Orleans, LA

Planning Committee

Sandy Bihlmeyer, M.Ed.
Senior Project Manager
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA

Sheila Lucas, CMEP
Activity Director
National Association for Continuing Education
Plantation, FL

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL

Gregg Sherman, MD
Course Director
Chief Medical Officer
National Association for Continuing Education
Plantation, FL

Cassandra A. McCullough, MBA

Chief Executive Officer

Association of Black Cardiologists

New York, NY

Sponsored and Certified By
Association of Black Cardiologists Inc. & National Association for Continuing Education
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 3.0 contact hours of continuing education, which includes 0.75 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc; and an independent medical educational grant from Novo Nordisk, Inc.